Skip to content

Nutex Health Inc. NUTX Line of Credit Outstanding

Line of Credit Outstanding at other companies

Phibro Animal Health logo
Phibro Animal HealthPAHC
$115M+25.0%

Other financials

Income statement

See full
Revenue$216.5M+2.2%
Gross profit$91.7M-22.5%
Operating income$81.3M+0.7%
Net income$46.8M+121%
EPS (diluted)$6.52+95.8%

Balance sheet

See full
Cash & equivalents$210.6M+149%
Total debt$348.9M+4.4%
Total equity$346.3M+75.7%
Total assets$957.3M+25.6%

Cash flow

See full
Operating cash flow$75.5M+48.2%
CapEx$1.2M+1,777%
Free cash flow$74.3M+46.0%

Valuation

See full
Market cap$1.02B+60.5%
Enterprise value$1.15B+30.8%
P/E10.5×+2.0×
P/S1.2×+0.1×

Profitability

See full
Gross margin47.5%-1.3pp
Operating margin31.4%-2.2pp
Net margin11%-0.9pp
FCF margin30.6%+19.4pp

Returns & leverage

See full
Return on equity35.5%-21.2pp
Debt / equity-0.7×
Current ratio3.1×+0.9×

Where this comes from

Reported directly by Nutex Health Inc. in its filing.

Tagged under the XBRL concept us-gaap:LinesOfCreditCurrent.

The official record: Nutex Health Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nutex Health Inc.'s line of credit outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nutex Health Inc.'s line of credit outstanding?
Nutex Health Inc. (NUTX) reported line of credit outstanding of $146K in Q1 2026.
How has Nutex Health Inc.'s line of credit outstanding changed year-over-year?
Nutex Health Inc.'s line of credit outstanding decreased by 98.0% year-over-year, from $7.13M to $146K.
What is the long-term trend for Nutex Health Inc.'s line of credit outstanding?
Over 4 years (2021 to 2025), Nutex Health Inc.'s line of credit outstanding has grown at a 79.0% compound annual growth rate (CAGR), from $72.06K to $740K.
What does line of credit outstanding mean?
This represents the total principal amount drawn and currently owed by the company under its revolving credit facilities. It serves as a primary indicator of short-term liquidity usage and the company's reliance on external debt financing to fund ongoing operations or working capital needs.